Experienced, Savvy Board of Directors at Helm of Kallo, Inc. (KALO)

In 2010, global expenditures for healthcare reached $6.3 trillion. Many factors, including increasing numbers of people with chronic diseases, a growing global elderly population and the increased need for medical attention that comes with it, and the ballooning of health conditions arising from unhealthy lifestyle choices, contributed to that jump.

Global demand for healthcare is projected to increase as these influences become more pronounced, and as costs rise to cover the growing healthcare organizational expenditures arising from meeting that demand. Kallo, a healthcare information technology company, has developed a suite of technologies and products to help healthcare organizations contain and reduce costs, implement better methods for monitoring and treating patient medical conditions, and increasing healthcare accessibility to populations in remote, hard-to-reach locales. The company’s four technologies aim at streamlining and building excellence in processes, existing information systems, communications, resources, and work flows, and overall care delivery.

Both the company leadership and products and technologies have been found to be in compliance with their related benchmarks for measuring and gauging effectiveness. Particularly, Kallo’s board of directors is made up of highly capable professionals with rich and diverse industry knowledge bases and backgrounds, enhancing the board’s ability to drive efforts of bringing cutting-edge healthcare IT solutions to light and enhancing healthcare delivery standards and reach across the world. The board members have close to 140 years of combined professional experience between them, committing themselves to the same high performance and ethical standards quality they seek to foster in Kallo products. They have implemented a culture of high expectations for integrity, accountability, excellence, innovation support, and leadership, in order to offer an even stronger value proposition to Kallo product users and shareholders.

Kallo’s board of directors includes:

• Mr. John Cecil (Chairman and CEO, Board of Directors Member)

Mr. Cecil leverages 26 years of healthcare industry experience and insights to inform his decision-making as Kallo’s Chairman and CEO. He is responsible for accomplishments such as the invention of the technology and procedure behind depth-of-anesthesia monitoring and non-invasive blood group testing. He also was a part of the research team behind the developments of the electro-hydraulic shockwave lithotripter, laser lithotripter and transurethral microwave therapy systems.

Mr. Cecil has held demanding management positions at the Vice President and Director levels in India for entities such as GE Medical Systems, Majoris Systems, and Satyam Computer Service Ltd., and a senior healthcare architect role with Sun Microsystems. He holds a Bachelor’s Degree in Electrical Engineering, a Master of Science Degree in Biomedical Engineering, and a Post Graduate Diploma in Medical Equipment Technology.

• Mr. Vince Leitao (President and COO, Board of Directors Member)

With over 32 years of senior sales and marketing role experience in healthcare, pharmaceuticals, and medical businesses, Mr. Leitao is a driving force behind Kallo’s business and strategy development efforts. He draws upon a deep knowledge and experience of strategizing, planning, and executing challenging sales and marketing plans.

Over the course of his career, Mr. Leitao demonstrated a great ability to attract and retain top talent, as well as make business opportunities and product development flourish. Since he moved to Canada in the early 1990s, he has worked with companies such as Procter & Gamble and E. Merck; he also served as Sales Director and then Vice President of Sales, for Genpharm/Gennium Pharma before being promoted to Director of Sales for doubling territory sales for three consecutive years. He also has relationship-building experience with large medical and pharmaceutical channel partners at multiple levels, and is the founder of Goapharma as well. Leveraging premier presentation skills and fluency in five languages, Mr. Leitao brings a wide range of knowledge and expertise to Kallo’s mission and efforts.

• Mr. Samuel L. Baker (Secretary and Legal Counsel, Board of Directors Member)

Mr. Baker has deep roots in legal expertise and strategy development, having served in demanding legal roles for 48 years. He is a Senior Partner at Baker Law Firm, where he has given legal counsel to multiple Fortune 500 and companies and other notable multinational enterprises. He is also a Founding Member and Canadian Representative to the Asian-Pacific Lawyers’ Association.

Mr. Baker also brings experience from other fields, serving as the Director of the Canada-Netherlands and Canada-Finland Chambers of Commerce, and the President of the Canada Scandinavian Business Association. With multiple fellowships, he is a published author of works on international transactions, joint ventures, technology transfers, Canadian business establishment, and many other subject matter focuses.

• Mr. Lloyd Chiotti (Board of Directors Member)

Mr. Chiotti boasts of over 30 years of business experience in the natural gas industry. He has worked with Enbridge Gas Distribution (formerly The Consumers Gas Company) for over three decades. Among the many senior management positions he has held include Director of Information Services and multiple Regional General Manager posts for Operations. He has recently promoted to the newly created position of Director of Distribution Asset Management, where he is now responsible for supervising the development of Enbridge Gas Distribution’s Strategic Asset Plan.

Mr. Chiotti is a graduate of the University of Toronto, with Bachelor’s in Engineering and a Master of Business Administration. He maintains active involvement in natural gas enterprises in other ways as well, serving as the Chair of the Asset Management Task Force of the Canadian Gas Association and keeping active membership in the Distribution Working Committee of the International Gas Union. Throughout his professional career, Mr. Chiotti additionally has served on numerous non-profit boards dedicated to medical and general well-being, business excellence and ethics, and the promotion of the fine arts.

For more information regarding Kallo, its leadership, and its initiatives, visit: www.kallo.ca

QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net